October 16-19, 2024 | New York City |
Dr. Parekh completed his clinical training in Hematology and Oncology and postdoctoral training in Dr. Ari Melnick’s lab at the Albert Einstein College of Medicine. He is the Director of Myeloma Translational Research and a Professor in Hematology-Oncology and Oncological Sciences at the Icahn School of Medicine at Mount Sinai. Dr. Parekh’s research focuses on the pathogenesis of hematological malignancies and the development of individualized, precision-medicine therapies for these malignancies. His lab uses an integrated systems biology approach to study genome-wide methylation, gene expression, and DNA sequence variation to understand pathogenesis, develop biomarkers and guide personalized therapy in B cell malignancies, particularly Multiple Myeloma and Non-Hodgkin’s lymphoma.